Overview
Ahzantive is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It’s also indicated for macular edema following retinal vein…

Overview
Eylea is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It is for individuals who have abnormal blood vessel growth under…

Overview
Izervay is approved by the U.S. Food and Drug Administration (FDA) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Izervay is also known by its drug name…

Overview
Lucentis is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It is also indicated for macular edema following retinal vein…

Overview
Syfovre is approved by the U.S. Food and Drug Administration (FDA) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Syfovre is also known by its drug name…

Overview
Vabysmo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It’s prescribed for people who’ve developed abnormal blood vessels…